The stronger inhibitory effect on BChE suggests a potential role in the treatment of neurodegenerative diseases, while the inhibition of α‐glucosidase supports its potential application in managing metabolic disorders such as diabetes. The gene discussed is BCHE; the disease is metabolic disease.